Validation of Instruments for Pragmatic Clinical Trials for Overactive Bladder

PHASE1CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Overactive Bladder
Interventions
DRUG

Toviaz

Means of effectiveness, adherence, and utility instruments over time will be examined to evaluate whether changes are linear from baseline to 8 weeks and 3 months. We will demonstrate the validity and responsiveness of pragmatic instruments against existing established measures (Table 3).

Trial Locations (1)

19104

University of Pennsylvania 3400 Spruce Street-1000 Courtyard, Philadelphia

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

University of Pennsylvania

OTHER

NCT01925456 - Validation of Instruments for Pragmatic Clinical Trials for Overactive Bladder | Biotech Hunter | Biotech Hunter